About AVT
Browse Articles
Customer Services

Case report

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series

Kevin Peterson, Jean Ruelle, Marc Vekemans, Frederick P Siegal, Jane R Deayton, Robert Colebunders

Corresponding author name: Kevin Peterson
Corresponding author e-mail: kpeterson@itg.be

Citation: Antiviral Therapy 2012; 17:1097-1100
doi: 10.3851/IMP2303

Date accepted: 20 January 2012
Date published online: 15 August 2012


We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4+ T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.


Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.